PAA 2.94% 16.5¢ pharmaust limited

Ann: Investor Briefings & Webinar Notice, page-50

  1. 2,907 Posts.
    lightbulb Created with Sketch. 1071
    ........In discussions with Elanco for their MPL patent. .....

    Did he say this? What I got was the composition of matter IP which belong to Elanco run out worldwide by the end of next year (2025) so they don't represent a hinderance to the marketing, development and commercialisation of MPL.

    Nice to finally get full clarity on the IP expiry and the timing seems to confirm the deliberate "go-slow" by the previous regime although this was constantly denied. Full transparency by the good Dr T and his PAA team is certainly much appreciated
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $80.22M
Open High Low Value Volume
17.0¢ 18.0¢ 16.5¢ $210.6K 1.236M

Buyers (Bids)

No. Vol. Price($)
2 274938 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 15000 2
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.